Molecular Pathogenesis of Peripheral T Cell Lymphoma (Q38597997)

4 September 2017

title

Molecular Pathogenesis of Peripheral T Cell Lymphoma (English)

1 reference

4 September 2017

author name string

Mamiko Sakata-Yanagimoto

series ordinal

1

1 reference

4 September 2017

Shigeru Chiba

series ordinal

2

1 reference

4 September 2017

publication date

2 October 2015

1 reference

Current hematologic malignancy reports

4 September 2017

published in

1 reference

4 September 2017

volume

10

1 reference

4 September 2017

issue

4

1 reference

4 September 2017

page(s)

429-437

1 reference

Multistep tumorigenesis in peripheral T cell lymphoma

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

How are T(H)1 and T(H)2 effector cells made?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Peripheral T-cell lymphoma with follicular T-cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Advances in the understanding and management of angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Rho GTPases in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

ROQUIN/RC3H1 alterations are not found in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Disease-specific mutations in mature lymphoid neoplasms: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Comprehensive gene expression profiles of NK cell neoplasms identify vorinostat as an effective drug candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Frequent mutations of Fas gene in nasal NK/T cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

cFLIP regulation of lymphocyte activation and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

The Epstein-Barr virus and the pathogenesis of lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

PRDM1 is a tumor suppressor gene in natural killer cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

The anaplastic lymphoma kinase in the pathogenesis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

ALKoma: a cancer subtype with a shared target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

A murine xenograft model for human CD30+ anaplastic large cell lymphoma. Successful growth inhibition with an anti-CD30 antibody (HeFi-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

TET proteins and 5-methylcytosine oxidation in hematological cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

DNMT3A in haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

Heterozygosity for Roquinsan leads to angioimmunoblastic T-cell lymphoma-like tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-015-0289-7

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis

21 January 2018

1 reference

12 December 2020

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

1 reference

12 December 2020

Angioimmunoblastic T-cell lymphoma mice model

1 reference

12 December 2020

Somatic STAT3 mutations in large granular lymphocytic leukemia

1 reference

12 December 2020

Mice transgenic for NPM-ALK develop non-Hodgkin lymphomas

1 reference

12 December 2020

STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia

1 reference

12 December 2020

CD2 promoter regulated nucleophosmin-anaplastic lymphoma kinase in transgenic mice causes B lymphoid malignancy.

1 reference

12 December 2020

Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL)

1 reference

12 December 2020

The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease

1 reference

12 December 2020

Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.

1 reference

12 December 2020

Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas

1 reference

12 December 2020

Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas

1 reference

12 December 2020

TET2 and DNMT3A mutations in human T-cell lymphoma

1 reference

12 December 2020

LMP-1 induces survivin expression to inhibit cell apoptosis through the NF-κB and PI3K/Akt signaling pathways in nasal NK/T-cell lymphoma

1 reference

12 December 2020

10.1007/S11899-015-0289-7

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1036090637

0 references

1 reference